January 18, 2017 12:07 AM ET

Healthcare Equipment and Supplies

Company Overview of Roka Bioscience, Inc.

Company Overview

Roka Bioscience, Inc., a molecular diagnostics company, focuses on the development and commercialization of molecular assay technologies for the detection of foodborne pathogens in the United States. It provides Atlas instrument, a fully automated molecular diagnostic testing instrument to reduce labor costs and operator error in high-volume foodborne pathogen testing laboratories. The company also offers atlas detection assays that include molecular tests for Salmonella, Listeria, E. coli O157:H7, Shiga toxin- producing E.coli, and Listeria monocytogenes, as well as related consumable supplies. It serves food processors, third-party contract testing laboratories, and government regulatory a...

20 Independence Boulevard

Warren, NJ 07059

United States

Founded in 2009

90 Employees

Phone:

908-605-4700

Key Executives for Roka Bioscience, Inc.

Founder, Chief Executive Officer, President and Director
Age: 60
Total Annual Compensation: $649.2K
Chief Commercial Officer and Senior Vice President
Age: 51
Total Annual Compensation: $377.0K
Senior Advisor
Age: 59
Total Annual Compensation: $394.1K
Compensation as of Fiscal Year 2015.

Roka Bioscience, Inc. Key Developments

Roka Bioscience, Inc. Reports Unaudited Earnings Results for the Third Quarter and Nine Months Ended September 30, 2016

Roka Bioscience, Inc. reported unaudited earnings results for the third quarter and nine months ended September 30, 2016. For the quarter, the company's revenue was $1,885,000 compared to $1,508,000 a year ago. The increase in third quarter revenue year-over-year resulted from an increase in the number of Atlas® instruments placed with commercial customers and increased commercial utilization of the instruments. Loss from operations was $7,194,000 compared to $8,083,000 a year ago. Loss before income taxes was $7,573,000 compared to $8,487,000 a year ago. Net loss and comprehensive loss was $7,589,000 compared to $8,491,000 a year ago. Net loss applicable to common shareholders was $9,467,000 compared to $8,491,000 a year ago. Basic and diluted net loss per common share was $5.39 compared to $4.91 a year ago. For the nine moths, the company's revenue was $5,336,000 compared to $4,484,000 a year ago. Loss from operations was $22,110,000 compared to $24,994,000 a year ago. Loss before income taxes was $23,310,000 compared to $26,582,000 a year ago. Net loss and comprehensive loss was $23,324,000 compared to $26,592,000 a year ago. Net loss applicable to common shareholders was $25,202,000 compared to $26,592,000 a year ago. Basic and diluted net loss per common share was $14.37 compared to $15.40 a year ago.

Roka Bioscience, Inc. to Report Q3, 2016 Results on Nov 07, 2016

Roka Bioscience, Inc. announced that they will report Q3, 2016 results on Nov 07, 2016

Roka Bioscience, Inc., Q3 2016 Earnings Call, Nov 07, 2016

Roka Bioscience, Inc., Q3 2016 Earnings Call, Nov 07, 2016

Similar Private Companies By Industry

Company Name Region
.decimal, Inc. United States
20/20 GeneSystems, Inc. United States
20/20 Imaging LLC United States
21st Century Scientific, Inc. United States
21X Corporation United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
September 16, 2016
--
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Roka Bioscience, Inc., please visit www.rokabio.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.